The focal adhesion kinase (FAK)/PI3K-Akt signaling pathway and JAK-STAT pathway were characterized as cellular signaling pathways unique to S:E fusion-positive prostate cancer. The gene discussed is PTK2; the disease is prostate carcinoma.